TABLE 2.
Clinical characteristics of NAFLD and healthy subjects assessed for plasma biomarker measurements.
| Characteristics | NAFLD (N = 67) |
Healthy controls (N = 78) |
|---|---|---|
| Sex (male, female) | 22, 45 | 47, 32 |
| Age (years), mean ± SD | 64.7 ± 8.3 | 53.7 ± 16.8 |
| African American (n, %) | 1 (1.5%) | 8 (10.3) |
| European American (n, %) | 56 (82.1%) | 45 (57.7) |
| Native American (n, %) | 6 (8.9) | 1 (1.2) |
| Ethnicity: Latino (n, %) | 27 (41.8) | 10 (12.8) |
| Type 2 diabetes (n, %) | 35 (52.2) | NA |
| Hypertension (n, %) | 47 (70.1) | NA |
| Dyslipidemia | 27 (40.3) | NA |